Having trouble viewing this email? View in your browser.
ESCMID Logo

8 September 2020
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

ECCVID: View the programme and get to know the keynote Speakers

On the ESCMID website you can now explore the scientific programme and read the biographies of the keynote speakers. Don’t miss highlights like Prof. Arturo Casadevall (USA) talking on the use of convalescent plasma for COVID-19 treatment, or ECDC director Dr. Andrea Ammon presenting on the multifaceted response to COVID-19 in the European Union.

Don’t forget that ESCMID Members can benefit from a discounted registration rate of just EUR 40, and members from low-income countries can register free of charge.

› Read more

ESCMID call for new guidelines projects 2020

ESCMID members and ESCMID Study Groups are invited to submit proposals for clinical practice guidelines projects in the following topics:

1. Diagnosis and treatment of Community Acquired Pneumonia;
2. Diagnosis and treatment of Brain Abscess management;
3. Update of the 2014 ESCMID guideline of prevention of infections due to MDR-GN

The deadline for project submission is
01/11/2020.
Full details can be found in the call text here.
For any questions, please write to guidancedocuments@escmid.org.

› Read more

Apply for one of 50 Funded Observerships from 10.09.2020

ESCMID is opening the first call for Observerships in 2020 this Thursday, 10 September at 12:00 CEST. As it is difficult to predict precisely when in-person exchanges and travelling will be easily possible again, visits should not be planned before April 2021.

ESCMID believes that it is worthwhile to continue this successful and valuable initiative, despite the difficult times.

In case of questions, please contact:
observership@escmid.org.

› Read more
 

EUCIC Websymposium – 8 October 2020

The EUCIC local module, ‘Infection and Resistance Prevention in the Regional Healthcare network’ will be held as an all-day online websymposium on 8 October 2020.

The main goal of the webinar is to introduce participants to the role and strengths of infection prevention and control in a regional health-care network, especially focusing on AMR as well as the regional spread of SARS-CoV-2.

Find out more and register on the EUCIC Local Modules page.

› Read more
 

First announcement: G-I-N interactive panels and masterclasses on guideline development and implementation

The Guideline International Network has developed a unique programme of four individual online sessions with global experts who will present on the pressing issues affecting the guideline community today.

The webinars (via Zoom) will focus on issues related to evidence synthesis and their impact on health recommendations and guidelines that have achieved much greater attention during the COVID-19 pandemic than perhaps ever before.

The sessions will take place as follows (UK time):
Session 1 - Quality of evidence for guidelines and recommendations, 30/09/2020, 10:00-12:00
Session 2 - Rapid Guideline Development, 30/09/2020, 16:00 - 18:00
Session 3 - Recommendation Mapping, 1/10/2020, 14:00 - 16:00
Session 4 - Living Recommendations, 2/10/2020, 14:00 - 16:00

Registration information will follow soon!

› Read more
 

The European Society for Clinical Virology (ESCV) invites you to attend the ESCV Virtual Meeting on COVID-19

While having 2020 as a year of crisis because of SARS-CoV-2 and while the pandemic is still ongoing, the European Society for Clinical Virology is organizing a timely, virtual, meeting focusing on COVID-19 which will showcase the latest and most pertinent topics in COVID-19 and open them up for discussion.

This meeting will bring together a worldwide community, offering the chance to follow up and discuss the ongoing pandemic from our individual perspectives.

The meeting is free of charge for all participants all that we ask is that you register in advance.

We look forward to welcoming you on September 9, 2020 for the ESCV Virtual Meeting on COVID-19!

Prof. Mariet Feltkamp, ESCV President
Prof. Pamela Vallely & Prof. Paul Klapper, Virtual Meeting Co-Chairs

› Read more
 

CMI Highlight: Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

The study aimed at estimating the association of tocilizumab and corticosteroids with the risk of intubation or death in COVID-19 patients with hyperinflammatory state according to clinical and laboratory parameters. A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 with clinical and laboratory data indicative of hyperinflammatory state.

In this observational, multicentre, propensity score-adjusted study, tocilizumab was associated with lower hazards of intubation or death in patients with COVID-19 presenting with clinical and laboratory data suggestive of hyperinflammatory state. The association with PDC was also significant in the analysis with the IPWT but not with other adjustments, although the estimations are informative. On the other hand, authors’ could not find a significant association of IHDC or combination therapy with outcomes. In conclusion, Tocilizumab might be useful in COVID-19 patients with hyperinflammatory state and should be prioritized for randomized trials.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.